Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue

Biomaterials

Volumn 30, Issue 35, 2009, Pages 6695-6701

  Syedain, Zeeshan H ^a   Bjork, Jason ^b   Sando, Lillian ^c   Tranquillo, Robert T ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Minnesota   (United States)

^c CSIRO   (Australia)

Author keywords

Cross linking; Fibrin; Fibroblast; Tissue engineering

Indexed keywords

ADVERSE EFFECT; BLUE LIGHT; CELL VIABILITY; COLLAGEN CONTENT; COLLAGEN DEPOSITION; CONNECTIVE TISSUES; CYCLIC DISTENSIONS; DETRIMENTAL EFFECTS; FIBRIN; FIBRIN GELS; GEL COMPACTION; INCUBATION PERIODS; LONG-TERM CULTURE; MECHANICAL CONSTRAINTS; PHOTOCHEMICAL CROSS-LINKING; PHOTOCROSS-LINKING; TISSUE FABRICATION; TISSUE GROWTH; TRACTION FORCES; TUBULAR CONSTRUCTS;

AMINO ACIDS; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; COLLAGEN; COMPACTION; FIBROBLASTS; GELATION; GELS; MUSCULOSKELETAL SYSTEM; RUTHENIUM; STIFFNESS; SYNCHROTRONS; TISSUE ENGINEERING; TRACTION (FRICTION);

TISSUE;

COLLAGEN; FIBRIN; RUTHENIUM;

ARTICLE; BLUE LIGHT; CELL PROLIFERATION; CELL VIABILITY; CONNECTIVE TISSUE; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; NEWBORN; PRIORITY JOURNAL; RIGIDITY; TISSUE ENGINEERING; TISSUE GROWTH; YOUNG MODULUS;

BIOCOMPATIBLE MATERIALS; CATALYSIS; CELL SURVIVAL; CELLS, CULTURED; COMPRESSIVE STRENGTH; CONNECTIVE TISSUE; CROSS-LINKING REAGENTS; ETHIDIUM; FIBRIN; FIBROBLASTS; FLUORESCEINS; FLUORESCENT DYES; GELS; HUMANS; INFANT, NEWBORN; MATERIALS TESTING; PHOTOCHEMISTRY; RUTHENIUM; SKIN; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TYROSINE;

EID: 70349883925     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.08.039     Document Type: Article

References (30)

1. Clark R.A., Nielsen L.D., Welch M.P., and McPherson J.M. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci 108 Pt 3 (1995) 1251-1261
2. Grassl E.D., Oegema T.R., and Tranquillo R.T. Fibrin as an alternative biopolymer to type I collagen for fabrication of a media-equivalent. J Biomed Mater Res 60 4 (2002) 607-612
3. Long J.J., and Tranquillo R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22 4 (2003) 339-350
4. Grassl E.D., Oegema T.R., and Tranquillo R.T. A fibrin-based arterial media equivalent. J Biomed Mater Res 66 3 (2003) 550-561
5. Robinson P.S., Johnson S.L., Evans M.C., Barocas V.H., and Tranquillo R.T. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng Part A 14 1 (2008) 83-95
6. Isenberg B.C., Williams C., and Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 98 1 (2006) 25-35
7. Yao L., Swartz D.D., Gugino S.F., Russell J.A., and Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 11 7-8 (2005) 991-1003
8. Flanagan T.C., Cornelissen C., Koch S., Tschoeke B., Sachweh J.S., Schmitz-Rode T., et al. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28 23 (2007) 3388-3397
9. Syedain Z.H., and Tranquillo R.T. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30 25 (2009) 4078-4084
10. Black LD, Meyers JD, Weinbaum JS, Shvelidze YA, Tranquillo RT. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A 2009, [epub ahead of print].
11. Birla R., Dhawan V., Huang Y.C., Lytle I., Tiranathanagul K., and Brown D. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities. Artif Organs 32 9 (2008) 684-691
12. Dare E.V., Griffith M., Poitras P., Wang T., Dervin G.F., Giulivi A., et al. Fibrin sealants from fresh or fresh/frozen plasma as scaffolds for in vitro articular cartilage regeneration. Tissue Eng Part A 15 8 (2009) 2285-2297
13. Neidert M.R., and Tranquillo R.T. Tissue-engineered valves with commissural alignment. Tissue Eng 12 4 (2006) 891-903
14. Syedain Z.H., Weinberg J.S., and Tranquillo R.T. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A 105 18 (2008) 6537-6542
15. Elvin C.M., Brownlee A.G., Huson M.G., Tebb T.A., Kim M., Lyons R.E., et al. The development of photochemically crosslinked native fibrinogen as a rapidly formed and mechanically strong surgical tissue sealant. Biomaterials 30 11 (2009) 2059-2065
16. Fancy D.A., and Kodadek T. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A 96 11 (1999) 6020-6024
17. Isenberg B.C., Williams C., and Tranquillo R.T. Endothelialization and flow conditioning of fibrin-based media-equivalents. Ann Biomed Eng 34 6 (2006) 971-985
18. Balestrini J.L., and Billiar K.L. Equibiaxial cyclic stretch stimulates fibroblasts to rapidly remodel fibrin. J Biomech 39 16 (2006) 2983-2990
19. Ahlfors J.E., and Billiar K.L. Biomechanical and biochemical characteristics of a human fibroblast-produced and remodeled matrix. Biomaterials 28 13 (2007) 2183-2191
20. Cummings C.L., Gawlitta D., Nerem R.M., and Stegemann J.P. Properties of engineered vascular constructs made from collagen, fibrin, collagen-fibrin mixtures. Biomaterials 25 17 (2004) 3699-3706
21. Tuan T.L., Song A., Chang S., Younai S., and Nimni M.E. In vitro fibroplasia: matrix contraction, cell growth, collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 223 1 (1996) 127-134
22. Neidert M.R., Lee E.S., Oegema T.R., and Tranquillo R.T. Enhanced fibrin remodeling in vitro with TGF-b1, insulin and plasmin for improved tissue-equivalents. Biomaterials 23 17 (2002) 3717-3731
23. Stegemann H., and Stalder K. Determination of hydroxyproline. Clin Chim Acta 18 2 (1967) 267-273
24. Kim Y.J., Sah R.L.Y., Doong J.Y.H., and Grodzinsky A.J. Fluorometric assay of DNA in cartilage explants using HOECHST-33258. Anal Biochem 174 1 (1988) 168-176
25. Tuan T.L., and Grinnell F. Fibronectin and fibrinolysis are not required for fibrin gel contraction by human skin fibroblasts. J Cell Physiol 140 3 (1989) 577-583
26. Abe M., Ho C.H., Kamm K.E., and Grinnell F. Different molecular motors mediate platelet-derived growth factor and lysophosphatidic acid-stimulated floating collagen matrix contraction. J Biol Chem 278 48 (2003) 47707-47712
27. Beningo K.A., Hamao K., Dembo M., Wang Y.L., and Hosoya H. Traction forces of fibroblasts are regulated by the Rho-dependent kinase but not by the myosin light chain kinase. Arch Biochem Biophys 456 2 (2006) 224-231
28. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., et al. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 57 5 (2000) 976-983
29. Allingham J.S., Smith R., and Rayment I. The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol 12 4 (2005) 378-379
30. Ho W., Tawil B., Dunn J.C., and Wu B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12 6 (2006) 1587-1595